Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

RemSleep Holdings (RMSL) Cash & Equivalents (2022 - 2025)

RemSleep Holdings' Cash & Equivalents history spans 6 years, with the latest figure at $343948.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 35.68% year-over-year to $343948.0; the TTM value through Sep 2025 reached $343948.0, down 35.68%, while the annual FY2024 figure was $463343.0, 35.57% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $343948.0 at RemSleep Holdings, down from $415975.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.0 million in Q1 2022 and bottomed at $343948.0 in Q3 2025.
  • The 4-year median for Cash & Equivalents is $730625.0 (2024), against an average of $1.2 million.
  • The largest annual shift saw Cash & Equivalents tumbled 63.51% in 2023 before it crashed 30.57% in 2025.
  • A 4-year view of Cash & Equivalents shows it stood at $1.8 million in 2022, then crashed by 60.96% to $719100.0 in 2023, then tumbled by 35.57% to $463343.0 in 2024, then fell by 25.77% to $343948.0 in 2025.
  • Per Business Quant, the three most recent readings for RMSL's Cash & Equivalents are $343948.0 (Q3 2025), $415975.0 (Q2 2025), and $507247.0 (Q1 2025).